 | Up a level |
Garczyk, Stefan, Ortiz-Bruechle, Nadina, Schneider, Ursula, Lurje, Isabella, Guricova, Karolina, Gaisa, Nadine T., Lorsy, Eva, Lindemann-Docter, Katharina, Heidenreich, Axel and Knuechel, Ruth (2020). Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder. Am. J. Pathol., 190 (2). S. 323 - 333. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1525-2191
Pfister, David, Porres, Daniel, Heidenreich, Axel, Heidegger, Isabel, Knuechel, Ruth, Steib, Florian, Behrendt, Florian F. and Verburg, Frederik A. (2016). Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with Ga-68-PSMA-HBED-CC than with F-18-Fluoroethylcholine PET/CT. Eur. J. Nucl. Med. Mol. Imaging, 43 (8). S. 1410 - 1418. NEW YORK: SPRINGER. ISSN 1619-7089
Rose, Michael, Bringezu, Sarah, Godfrey, Laura, Fiedler, David, Gaisa, Nadine T., Koch, Maximilian, Bach, Christian, Fuessel, Susanne, Herr, Alexander, Huebner, Doreen, Ellinger, Joerg, Pfister, David, Knuechel, Ruth, Wirth, Manfred P., Boehme, Manja and Dahl, Edgar (2020). ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer. Int. J. Mol. Sci., 21 (3). BASEL: MDPI. ISSN 1422-0067
Rueschoff, Josef, Baretton, Gustavo, Blaeker, Hendrik, Dietmaier, Wolfgang, Dietel, Manfred, Hartmann, Arndt, Horn, Lars-Christian, Joehrens, Korinna, Kirchner, Thomas, Knuechel, Ruth, Mayr, Doris, Merkelbach-Bruse, Sabine, Schildhaus, Hans-Ulrich, Schirmacher, Peter, Tiemann, Markus, Tiemann, Katharina, Weichert, Wilko and Buettner, Reinhard (2021). MSI testing What's new? What should be considered? Pathologe, 42 (SUPPL 1). S. 110 - 119. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1963
Schnitzler, Tician, Ortiz-Bruechle, Nadina, Schneider, Ursula, Lurje, Isabella, Guricova, Karolina, Buchner, Alexander 
ORCID: 0000-0001-7895-7070, Schulz, Gerald Bastian, Heidenreich, Axel, Gaisa, Nadine Therese, Knuechel, Ruth and Garczyk, Stefan
(2020).
Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.
Cell. Oncol., 43 (5).
S. 807 - 820.
DORDRECHT:
SPRINGER.
ISSN 2211-3436